ARPA-H selects UpDoc, Tempus AI and Atman Health for new AI heart-disease program
read at Endpoints ↗Positive
ARPA-H announced a new initiative called ADVOCATE that will bring together three companies to develop AI-driven tools for managing heart disease.
The selected firms - UpDoc, Tempus AI, and Atman Health - will work on creating agentic AI systems that meet FDA requirements, aiming to improve diagnosis, treatment planning, and patient monitoring.
The program reflects growing federal interest in applying advanced AI to cardiovascular care and could accelerate the availability of regulated digital health solutions.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “ARPA-H picks UpDoc, Tempus and Atman to build AI tools for heart disease”
read at Endpoints ↗83 words · retrieved 31m ago
comments(0)
5-min edit window · permanent after that